Detailed information for compound 1879992

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 368.339 | Formula: C15H18F2N6O3
  • H donors: 2 H acceptors: 3 LogP: -1.62 Rotable bonds: 3
    Rule of 5 violations (Lipinski): 1
  • SMILES: Nc1ccn(c(=O)n1)[C@@H]1O[C@@H]([C@H](C1(F)F)O)CN1CCn2c(C1)ccn2
  • InChi: 1S/C15H18F2N6O3/c16-15(17)12(24)10(8-21-5-6-23-9(7-21)1-3-19-23)26-13(15)22-4-2-11(18)20-14(22)25/h1-4,10,12-13,24H,5-8H2,(H2,18,20,25)/t10-,12-,13-/m1/s1
  • InChiKey: MKUIYMQGVZUIHW-RAIGVLPGSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Leishmania major hypothetical protein, conserved 0.0109 0.0845 0.5
Onchocerca volvulus 0.0209 0.8318 0.8318
Brugia malayi SEA domain containing protein 0.0209 0.8318 0.8318
Loa Loa (eye worm) DOMON domain-containing protein 0.0209 0.8318 0.8318
Schistosoma mansoni hypothetical protein 0.0109 0.0845 0.0261
Onchocerca volvulus 0.0109 0.0845 0.0845
Loa Loa (eye worm) TK/ROR protein kinase 0.0109 0.0845 0.0845
Plasmodium vivax cysteine repeat modular protein 1, putative 0.0109 0.0845 0.5
Brugia malayi Kringle domain containing protein 0.0109 0.0845 0.0845
Echinococcus multilocularis tissue type plasminogen activator 0.0109 0.0845 0.5
Onchocerca volvulus 0.0209 0.8318 0.8318
Brugia malayi Protein kinase domain containing protein 0.0109 0.0845 0.0845
Loa Loa (eye worm) hypothetical protein 0.0209 0.8318 0.8318
Toxoplasma gondii kringle domain-containing protein 0.0109 0.0845 0.5
Onchocerca volvulus 0.0232 1 1
Onchocerca volvulus 0.0209 0.8318 0.8318
Trypanosoma cruzi hypothetical protein, conserved 0.0109 0.0845 0.5
Loa Loa (eye worm) hypothetical protein 0.0109 0.0845 0.0845
Schistosoma mansoni hypothetical protein 0.0209 0.8318 1
Plasmodium falciparum cysteine repeat modular protein 1 0.0109 0.0845 0.5
Onchocerca volvulus 0.0209 0.8318 0.8318
Loa Loa (eye worm) hypothetical protein 0.0232 1 1
Echinococcus granulosus tissue type plasminogen activator 0.0109 0.0845 0.5
Loa Loa (eye worm) hypothetical protein 0.0115 0.1289 0.1289

Activities

Activity type Activity value Assay description Source Reference
Inhibition (binding) Inhibition of RRM1 in human CEM cells assessed as depletion of dCTP level at 1 uM after 2 hrs by HPLC analysis ChEMBL. 24588962
Inhibition (binding) Inhibition of RRM1 in human CEM cells assessed as depletion of dGTP level at 1 uM after 2 hrs by HPLC analysis ChEMBL. 24588962
Inhibition (binding) Inhibition of RRM1 in human U2OS cells assessed as gammaH2AX induction after 2 hrs by FITC/propidium iodide-staining based flow cytometry in presence of SCH900776 ChEMBL. 24588962
Inhibition (binding) Inhibition of RRM1 in human U2OS cells assessed as gammaH2AX induction at 0.5 to 125 uM after 2 hrs by FITC/propidium iodide-staining based flow cytometry in absence of SCH900776 ChEMBL. 24588962
Inhibition (binding) Inhibition of RRM1 in human U2OS cells assessed as gammaH2AX induction at 0.5 to 125 uM after 2 hrs by FITC/propidium iodide-staining based flow cytometry in presence of SCH900776 ChEMBL. 24588962
Inhibition (binding) Inhibition of RRM1 in human CEM cells assessed as depletion of dATP level at 1 uM after 2 hrs by HPLC analysis ChEMBL. 24588962
Inhibition (binding) = 32 % Inhibition of human RRM1/RNR2 activity using CDP as substrate assessed as reduction of dCDP production at 100 uM preincubated for 30 mins followed by substrate addition measured after 1 hr by NMR spectroscopy ChEMBL. 24588962
Inhibition (binding) = 32 % Inhibition of human RRM1/RNR2 activity using CDP as substrate assessed as reduction of CDP consumption at 100 uM preincubated for 30 mins followed by substrate addition measured after 1 hr by NMR spectroscopy ChEMBL. 24588962

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.